Jonathan Yon
Stock Analyst at Credit Suisse
(2.09)
# 3,001
Out of 5,245 analysts
16
Total ratings
54.55%
Success rate
4.87%
Average return
Main Sectors:
Stocks Rated by Jonathan Yon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UHS Universal Health Services | Maintains: Outperform | $163 → $169 | $157.80 | +7.10% | 3 | Jul 27, 2023 | |
| PRVA Privia Health Group | Reiterates: Outperform | $41 | $22.79 | +79.90% | 2 | Jun 22, 2023 | |
| CYH Community Health Systems | Maintains: Neutral | $8.5 → $7.4 | $2.80 | +164.29% | 1 | May 3, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $31 → $32 | $13.05 | +145.21% | 1 | Feb 23, 2023 | |
| SLQT SelectQuote | Maintains: Neutral | $1 → $3 | $1.00 | +200.00% | 1 | Feb 22, 2023 | |
| MD Pediatrix Medical Group | Maintains: Outperform | $27 → $23 | $21.26 | +8.18% | 3 | Feb 22, 2023 | |
| HCA HCA Healthcare | Maintains: Outperform | $296 → $260 | $394.07 | -34.02% | 1 | Apr 25, 2022 | |
| CLOV Clover Health Investments | Downgrades: Underperform | $9 → $3.5 | $3.55 | -1.41% | 2 | Jan 7, 2022 | |
| CI The Cigna Group | Maintains: Outperform | $270 → $300 | $286.24 | +4.81% | 1 | Nov 8, 2021 | |
| CNC Centene | Maintains: Neutral | $74 → $70 | $59.14 | +18.36% | 1 | Sep 14, 2021 |
Universal Health Services
Jul 27, 2023
Maintains: Outperform
Price Target: $163 → $169
Current: $157.80
Upside: +7.10%
Privia Health Group
Jun 22, 2023
Reiterates: Outperform
Price Target: $41
Current: $22.79
Upside: +79.90%
Community Health Systems
May 3, 2023
Maintains: Neutral
Price Target: $8.5 → $7.4
Current: $2.80
Upside: +164.29%
Cross Country Healthcare
Feb 23, 2023
Maintains: Neutral
Price Target: $31 → $32
Current: $13.05
Upside: +145.21%
SelectQuote
Feb 22, 2023
Maintains: Neutral
Price Target: $1 → $3
Current: $1.00
Upside: +200.00%
Pediatrix Medical Group
Feb 22, 2023
Maintains: Outperform
Price Target: $27 → $23
Current: $21.26
Upside: +8.18%
HCA Healthcare
Apr 25, 2022
Maintains: Outperform
Price Target: $296 → $260
Current: $394.07
Upside: -34.02%
Clover Health Investments
Jan 7, 2022
Downgrades: Underperform
Price Target: $9 → $3.5
Current: $3.55
Upside: -1.41%
The Cigna Group
Nov 8, 2021
Maintains: Outperform
Price Target: $270 → $300
Current: $286.24
Upside: +4.81%
Centene
Sep 14, 2021
Maintains: Neutral
Price Target: $74 → $70
Current: $59.14
Upside: +18.36%